Bluestar Adisseo Co
SSE:600299

Watchlist Manager
Bluestar Adisseo Co Logo
Bluestar Adisseo Co
SSE:600299
Watchlist
Price: 13.19 CNY -6.12% Market Closed
Market Cap: ¥40.6B

EV/EBIT

18.8
Current
4%
More Expensive
vs 3-y average of 18.1

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
18.8
=
Enterprise Value
¥42.6B
/
EBIT
¥2B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
18.8
=
Enterprise Value
¥42.6B
/
EBIT
¥2B

Valuation Scenarios

Bluestar Adisseo Co is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (18.1), the stock would be worth ¥12.73 (3% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-21%
Maximum Upside
+104%
Average Upside
33%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 18.8 ¥13.19
0%
3-Year Average 18.1 ¥12.73
-3%
5-Year Average 14.9 ¥10.46
-21%
Industry Average 38.3 ¥26.87
+104%
Country Average 28.9 ¥20.3
+54%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
¥42.6B
/
Jan 2026
¥2B
=
18.8
Current
¥42.6B
/
Dec 2026
¥1.9B
=
22.4
Forward
¥42.6B
/
Dec 2027
¥2.3B
=
18.6
Forward
¥42.6B
/
Dec 2028
¥2.8B
=
15
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
34rd
Based on 5 337 companies
34rd percentile
18.8
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Bluestar Adisseo Co
Glance View

Market Cap
40.6B CNY
Industry
Chemicals

In the bustling corridors of the global animal nutrition industry, Bluestar Adisseo Co. stands out as a vital player, shaping the future of sustainable feeding solutions. Born from the amalgamation of Adisseo Group and China National Bluestar Corporation, this company has positioned itself uniquely, bridging Western ingenuity with Eastern scale. The very heart of its operation beats with the synthesis of amino acids, vitamins, and essential enzymes that enhance livestock nutrition. By optimizing feed efficiency, Bluestar Adisseo doesn’t just help farmers yield healthier poultry and livestock; it also plays a critical role in reducing the environmental footprint associated with conventional farming practices. These nutritional supplements are crafted through advanced biotechnology and chemistry, ensuring precision and efficacy, which are the central pillars supporting the company's expansive revenue streams. Bluestar Adisseo’s business model is a testament to its strategic innovation and operational excellence. The company earns its keep through a diversified portfolio that extends across several continents, tapping into various markets through both direct sales and strategic partnerships. By continuously investing in R&D, Adisseo ensures its products align with evolving agricultural needs and regulatory requirements, thus maintaining a competitive edge. Moreover, the company's robust supply chain infrastructure allows for the efficient delivery of high-quality products to farmers globally, safeguarding its market share. It is this mastery over cost-effective production and logistical excellence, coupled with a commitment to sustainability, that keeps Bluestar Adisseo not only relevant but also thriving in the ever-competitive landscape of global animal nutrition.

Intrinsic Value
13.41 CNY
Undervaluation 2%
Intrinsic Value
Price ¥13.19
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett